PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.04%
Positive revenue growth while NXPI is negative. John Neff might see a notable competitive edge here.
0.29%
Positive gross profit growth while NXPI is negative. John Neff would see a clear operational edge over the competitor.
0.32%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
-0.96%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
297.09%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
294.29%
Positive EPS growth while NXPI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
297.06%
Positive diluted EPS growth while NXPI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.20%
Share reduction while NXPI is at 0.46%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.20%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.20%
Dividend growth of 0.20% while NXPI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-42.35%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-45.64%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
56.33%
10Y revenue/share CAGR at 50-75% of NXPI's 102.45%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
47.90%
5Y revenue/share CAGR similar to NXPI's 51.93%. Walter Schloss might see both companies benefiting from the same mid-term trends.
27.80%
3Y revenue/share CAGR above 1.5x NXPI's 4.69%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
134.19%
10Y OCF/share CAGR at 50-75% of NXPI's 205.53%. Martin Whitman might fear a structural deficiency in operational efficiency.
247.85%
5Y OCF/share CAGR at 75-90% of NXPI's 278.51%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
94.00%
3Y OCF/share CAGR above 1.5x NXPI's 14.04%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
178.55%
Net income/share CAGR above 1.5x NXPI's 106.27% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
324.95%
5Y net income/share CAGR at 75-90% of NXPI's 400.98%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
121.24%
3Y net income/share CAGR 75-90% of NXPI's 136.69%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
45.75%
Equity/share CAGR of 45.75% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
9.43%
Below 50% of NXPI's 868.35%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
9.04%
Below 50% of NXPI's 1936.37%. Michael Burry suspects a serious short-term disadvantage in building book value.
520.16%
Dividend/share CAGR of 520.16% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
196.58%
Dividend/share CAGR of 196.58% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
82.35%
3Y dividend/share CAGR of 82.35% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
13.77%
Our AR growth while NXPI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
3.83%
Inventory growth well above NXPI's 1.21%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.77%
Negative asset growth while NXPI invests at 0.32%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.16%
BV/share growth above 1.5x NXPI's 0.81%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.02%
Debt shrinking faster vs. NXPI's 0.20%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-0.26%
Our R&D shrinks while NXPI invests at 2.90%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
5.87%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.